Bozeman, Montana, United States
Class of 2027 TRUST Scholar
Pediatric Oncology Branch, NIH Clinical Center >Pharmacology & Experimental Therapeutics Section (PETS) under Dr. Brigitte Widemann & Dr. Andrea Gross (April 2022-2023) Conducted clinical research studying the efficacy of the MEK inhibitor, Selumetinib, in treating patients with Neurofibromatosis Type I (NFI). Focused on the impact of Selumetinib on cutaneous neurofibroma shrinkage and motor/functional outcomes. >Solid Tumor Biology Section under Dr. Troy McEachron (April 2021-2022) Conducted translational research studying the pathogenesis & tumor microenvironment of pediatric osteosarcoma, specifically the role of HIPPO pathway signaling dysregulation in tumor progression.
Studied the pathogenesis of Alzheimer’s Disease using multi-omics methodology in the laboratory of Dr. Edward Dratz.